{"organizations": [], "uuid": "2b8e8eb3828a0d54132db53357731aa49e23c213", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180329.html", "section_title": "Archive News &amp; Video for Thursday, 29 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-kobayashi-pharmaceutical-to-acquir/brief-kobayashi-pharmaceutical-to-acquire-china-based-pharmaceutical-firm-and-set-up-control-company-in-shanghai-idUSL3N1RB3O2", "country": "US", "domain_rank": 408, "title": "Kobayashi Pharmaceutical to acquire China-based pharmaceutical firm and set up control company in Shanghai", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.966, "site_type": "news", "published": "2018-03-29T16:11:00.000+03:00", "replies_count": 0, "uuid": "2b8e8eb3828a0d54132db53357731aa49e23c213"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-kobayashi-pharmaceutical-to-acquir/brief-kobayashi-pharmaceutical-to-acquire-china-based-pharmaceutical-firm-and-set-up-control-company-in-shanghai-idUSL3N1RB3O2", "ord_in_thread": 0, "title": "Kobayashi Pharmaceutical to acquire China-based pharmaceutical firm and set up control company in Shanghai", "locations": [], "entities": {"persons": [{"name": "jia", "sentiment": "negative"}], "locations": [{"name": "shanghai", "sentiment": "none"}], "organizations": [{"name": "kobayashi pharmaceutical", "sentiment": "negative"}, {"name": "reuters) - kobayashi pharmaceutical co ltd", "sentiment": "neutral"}, {"name": "beijing headline news", "sentiment": "none"}, {"name": "jiangsu zhongdan group co ltd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 29 (Reuters) - Kobayashi Pharmaceutical Co Ltd\n* Says it will acquire 100 percent stake in Jiangsu-based pharmaceutical firm from JIANGSU ZHONGDAN GROUP CO LTD, with undisclosed price, effective June 30\n* Says it will set up a control company in Shanghai, in April, to management business in China\nSource text in Japanese: goo.gl/y1iCgh\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "https://goo.gl/y1iCgh", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-03-29T16:11:00.000+03:00", "crawled": "2018-03-30T13:02:56.083+03:00", "highlightTitle": ""}